Cargando…
Angiotensin Inhibition, TGF-β and EMT in Cancer
SIMPLE SUMMARY: Angiotensin inhibitors are broadly applied in the treatment of renal and cardiovascular diseases. This review aims to show that these drugs have also been beneficial in cancer therapies. Underlying molecular mechanisms are elucidated. Angiotensin signaling and the antifibrotic proper...
Autores principales: | Pallasch, Fabian Bernhard, Schumacher, Udo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601465/ https://www.ncbi.nlm.nih.gov/pubmed/32998363 http://dx.doi.org/10.3390/cancers12102785 |
Ejemplares similares
-
TGF-β in developmental and fibrogenic EMTs
por: Lee, Jun Ho, et al.
Publicado: (2022) -
Organ Fibrosis and Autoimmunity: The Role of Inflammation in TGFβ-Dependent EMT
por: Sisto, Margherita, et al.
Publicado: (2021) -
Overexpression of SASH1 Inhibits TGF-β1-Induced EMT in Gastric Cancer Cells
por: Zong, Wei, et al.
Publicado: (2016) -
aV integrins and TGF-β-induced EMT: a circle of regulation
por: Mamuya, Fahmy A, et al.
Publicado: (2012) -
Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks
por: Zhang, Jingyu, et al.
Publicado: (2016)